Analytica Home
Analytica Contact

Leave nothing to chance

Case Study


SERVICES

CONTACT INFORMATION

United States

24 West 40th Street
New York, NY 10018
+1 212 686 4100

Germany

Meeraner Platz 1
79539 Lörrach
+49 7621 98687 0

Italy

Vicolo Stella 6
37121Verona
+39 045 800 8609

United Kingdom

66 Chiltern Street
LondonW1U 4JT
+44(0)20 3137 5800

France

10 Place de Catalogne
Paris 75014
+33 155 425 300

Canada

4818–4820, Saint Laurent Boulevard
Montreal
Quebec H2T1R5
+1 514 315 3550

Poland

8 Plk.Dabka Street
30-732 Krakow
+48 12 263 60 38

Spain

C/ Azcárraga,12a
33010 Oviedo
+34 985 793 704

Determine the economic ramifications of delayed tumor progression via a retrospective database analysis

Objectives: to understand the economic ramifications of delayed tumor progression

Research

  • Patients were identified via a tumor registry and linked to all other information (demographics, inpatient, outpatient, pharmacy)
ramifications of delayed tumor progression - research

Analyze

  • Descriptive Statistics
    • Age, race
    • Time to follow up
    • Death
    • Baseline stage, grade, node
    • Baseline labs
    • Scans
    • Initial treatment and other treatments
    • Progression status
    • PSA descriptives
  • Analysis of Progression as an outcome
    • Odds of progression
    • Time to progression
  • Analysis of Cost as an Outcome
    • Total cost by progression status
    • Total cost per year by progression status
    • Effect of progression on cost
    • Cost pre and post progression
    • Cost categorization analysis

Communicate

  • Results were presented at:
    • ASCO
    • AUA (epi/cost)
    • Journal of Urology Vol. 171, 2250–2254, June 2004
ramifications of delayed tumor progression  - Communicate